Gelteq (GELS) Cash from Operations (2023 - 2025)
Gelteq (GELS) posted quarterly Cash from Operations of 710866.45 for Q4 2025, up 69.76% year-over-year from 418747.72 in Q4 2024, and up 69.76% quarter-over-quarter from 2350754.9 in Q4 2024.
Gelteq (GELS) Cash from Operations (2023 - 2025) Analysis & Trends
Gelteq's Cash from Operations history runs 3 years deep, the most recent figure standing at 710866.45 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Gelteq | 5.98 Mn | 5.71 Mn | - | -710,866.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -710,866.45 |
| Dec 31, 2025 | -710,866.45 |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -279,386.89 |
| Dec 31, 2023 | -279,386.89 |